A new study compares the benefits and risks of taking GLP-1 medications for weight loss, including risks of dementia, ...

GLP-1RA weight-loss drugs provide health benefits but also pose risks, including pancreatitis, kidney problems, and ...

The study revealed that weight-loss drugs significantly benefit neurological and behavioral health, including decreased risks ...

News research shows GLP-1 medications may help treat a wide range of conditions, from addiction and dementia to heart disease ...

The study in Nature Medicine reveals that alongside weight loss benefits, GLP-1 medications like Ozempic and Mounjaro may ...

Learn more about a new study claiming that GLP-1s could be used to treat cognitive conditions like dementia, but may pose a risk to other vital organs.

Home Bladder Cancer Test: New Urine-Based Kit May Enable Early DiagnosisThe research team has developed a urine-based ...

Medicare, the national health program for nearly all Americans 65 and older, was created in 1965. As the program evolves, ...

Eli Lilly's Ozempic-rivaling weight-loss pill orforglipron could be available in early 2026. Its retatrutide may be as ...

Recent findings indicate that widely used weight-loss medications might lead to muscle loss, including vital heart muscle, ...

One of Novo Nordisk's next-generation obesity shots to follow up on the success of Wegovy helped patients lose 22% of their ...

As demand for weight-loss injections sold under brand names such as Ozempic and Wegovy continues to soar, a study has ...